Actualites Pharmaceutiques最新文献

筛选
英文 中文
Évaluez-vous !
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.014
Élisa Derrien (Rédactrice en chef)
{"title":"Évaluez-vous !","authors":"Élisa Derrien (Rédactrice en chef)","doi":"10.1016/j.actpha.2024.12.014","DOIUrl":"10.1016/j.actpha.2024.12.014","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 62-64"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’ordonnance numérique à l’heure de sa généralisation
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.001
Arthur Piraux (Pharmacien d’officine, maître de conférences en pratiques officinales)
{"title":"L’ordonnance numérique à l’heure de sa généralisation","authors":"Arthur Piraux (Pharmacien d’officine, maître de conférences en pratiques officinales)","doi":"10.1016/j.actpha.2024.12.001","DOIUrl":"10.1016/j.actpha.2024.12.001","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Page 1"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les troubles anxieux
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2025.01.001
Damien Malbos (Docteur en pharmacie)
{"title":"Les troubles anxieux","authors":"Damien Malbos (Docteur en pharmacie)","doi":"10.1016/j.actpha.2025.01.001","DOIUrl":"10.1016/j.actpha.2025.01.001","url":null,"abstract":"<div><div>Les troubles anxieux ont un impact important sur la qualité de la vie des personnes qui en souffrent. Ils sont à l’origine d’une souffrance nécessitant une prise en charge adaptée. L’officinal est bien souvent sollicité pour un conseil ou dans le cadre d’un traitement médicamenteux.</div></div><div><div>Anxiety disorders have a major impact on the quality of life of sufferers. They are the cause of suffering that requires appropriate treatment. Pharmacists are often called upon for advice, or as part of a medication regimen.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 20-25"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posture du pharmacien face aux psychotropes
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.007
Eiya Ayed (Docteure en pharmacie)
{"title":"Posture du pharmacien face aux psychotropes","authors":"Eiya Ayed (Docteure en pharmacie)","doi":"10.1016/j.actpha.2024.12.007","DOIUrl":"10.1016/j.actpha.2024.12.007","url":null,"abstract":"<div><div>Les troubles psychiques touchent un Français sur cinq, soit environ 13 millions de personnes chaque année. Il est donc important que le pharmacien sache quelle posture adopter face à ces patients au comptoir de l’officine.</div></div><div><div>Psychological disorders affect one in five French people, i.e. around 13 million people every year. It is therefore important for pharmacists to know how to deal with these patients at the pharmacy counter.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 28-32"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143360842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bienfaits du sport et de l’activité physique chez l’enfant et l’adolescent
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.011
Peggy André (Docteure en pharmacie)
{"title":"Bienfaits du sport et de l’activité physique chez l’enfant et l’adolescent","authors":"Peggy André (Docteure en pharmacie)","doi":"10.1016/j.actpha.2024.12.011","DOIUrl":"10.1016/j.actpha.2024.12.011","url":null,"abstract":"<div><div>Tous les enfants et adolescents devraient pratiquer 60 minutes d’activité physique ou sportive chaque jour. Un chiffre loin d’être atteint en France alors que l’inactivité physique et la sédentarité sont pourtant responsables du développement croissant, ces dernières décennies, des maladies chroniques non transmissibles à l’âge adulte. Le pharmacien, acteur de santé de proximité, est en première ligne pour faire passer le message aux familles et promouvoir la pratique sportive dès le plus jeune âge.</div></div><div><div>All children and adolescents should engage in 60 minutes of physical activity or sport every day. This figure is far from being achieved in France, despite the fact that physical inactivity and a sedentary lifestyle are responsible for the growing incidence of non-communicable chronic diseases in adulthood over recent decades. As a local health player, pharmacists are in the front line when it comes to getting the message across to families, and promoting the practice of sport from an early age.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 49-53"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dépistage du cancer de la prostate
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.012
Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal)
{"title":"Dépistage du cancer de la prostate","authors":"Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal)","doi":"10.1016/j.actpha.2024.12.012","DOIUrl":"10.1016/j.actpha.2024.12.012","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 55-56"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La santé mentale, une préoccupation partagée par tous les professionnels de santé
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.005
Damien Malbos (Docteur en pharmacie)
{"title":"La santé mentale, une préoccupation partagée par tous les professionnels de santé","authors":"Damien Malbos (Docteur en pharmacie)","doi":"10.1016/j.actpha.2024.12.005","DOIUrl":"10.1016/j.actpha.2024.12.005","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Page 19"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
livres
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2025.01.020
{"title":"livres","authors":"","doi":"10.1016/j.actpha.2025.01.020","DOIUrl":"10.1016/j.actpha.2025.01.020","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Page 7"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Captopril, hydrochlorothiazide et ibuprofène
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.004
Samuel Legeay (Maître de conférences des universités), Sébastien Faure (Professeur des universités)
{"title":"Captopril, hydrochlorothiazide et ibuprofène","authors":"Samuel Legeay (Maître de conférences des universités),&nbsp;Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2024.12.004","DOIUrl":"10.1016/j.actpha.2024.12.004","url":null,"abstract":"<div><div>L’association captopril-hydrochlorothiazide-ibuprofène peut entraîner une insuffisance rénale aiguë (IRA) qui se traduit cliniquement par des œdèmes, des nausées et vomissements, une fatigue et une confusion. Des spasmes et un coma peuvent également survenir en l’absence d’une prise en charge par un service d’urgences. Le pharmacien d’officine a un rôle indispensable à jouer dans la prévention de cette interaction, l’orientation des patients présentant une symptomatologie d’IRA et la sensibilisation des personnes traitées par anti-inflammatoire non stéroïdien.</div></div><div><div>The captopril-hydrochlorothiazide-ibuprofen combination can lead to acute renal failure (ARF), clinically manifested by edema, nausea and vomiting, fatigue and confusion. Spasms and coma may also occur in the absence of emergency care. The dispensing pharmacist has an indispensable role to play in preventing this interaction, referring patients with ARI symptoms and raising awareness among those being treated with non-steroidal anti-inflammatory drugs.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 14-17"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le zanubrutinib (Brukinsa®), un nouveau “tinib” antinéoplasique
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-02-01 DOI: 10.1016/j.actpha.2024.12.002
Jacques Buxeraud (Professeur des universités) , Sébastien Faure (Professeur des universités)
{"title":"Le zanubrutinib (Brukinsa®), un nouveau “tinib” antinéoplasique","authors":"Jacques Buxeraud (Professeur des universités) ,&nbsp;Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2024.12.002","DOIUrl":"10.1016/j.actpha.2024.12.002","url":null,"abstract":"<div><div>Le zanubrutinib est un nouvel antinéoplasique inhibiteur de la tyrosine kinase de Bruton disponible à l’officine. Il est indiqué dans le traitement de différentes formes de cancers dont des lymphomes et des leucémies.</div></div><div><div>Zanubrutinib is a new Bruton’s antineoplastic tyrosine kinase inhibitor available in pharmacies. It is indicated for the treatment of various forms of cancer, including lymphoma and leukemia.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 643","pages":"Pages 10-11"},"PeriodicalIF":0.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143294744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信